Rofecoxib-induced cholestatic hepatitis: treatment with molecular adsorbent recycling system (MARS).
Huster
Dominik
D
Schubert
Christian
C
Berr
Frieder
F
Mössner
Joachim
J
Caca
Karel
K
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002779:Cholestasis / Q000139:chemically induced* / Q000628:therapy*; D005260:Female; D006505:Hepatitis / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D019164:Liver, Artificial; D008875:Middle Aged; D016060:Sorption Detoxification; D013450:Sulfones
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib